The CD47-SIRPα axis is a promising target for cancer immunotherapies
Hao Yu, Xinxuan Zhou, Yiling Li, Bolei Li, Lei Cheng, Lei Cheng
Topics & Concepts
CD47Cancer immunotherapyCancerImmunotherapyImmune systemImmune checkpointCancer researchCancer cellPhagocytosisImmunologyBiologyGeneticsPhagocytosis and Immune RegulationImmune cells in cancerNanoplatforms for cancer theranostics